The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Progyny Inc (NASDAQ: PGNY) closed at $22.72 in the last session, down -3.11% from day before closing price of $23.45. In other words, the price has decreased by -$3.11 from its previous closing price. On the day, 1.68 million shares were traded. PGNY stock price reached its highest trading level at $23.18 during the session, while it also had its lowest trading level at $22.19.
Ratios:
We take a closer look at PGNY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.06. For the most recent quarter (mrq), Quick Ratio is recorded 2.62 and its Current Ratio is at 2.62. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 13, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $19.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 26 ’24 when Schlanger David J bought 150,000 shares for $14.68 per share. The transaction valued at 2,202,330 led to the insider holds 228,269 shares of the business.
Anevski Peter bought 209,500 shares of PGNY for $3,034,084 on Dec 23 ’24. The CHIEF EXECUTIVE OFFICER now owns 441,463 shares after completing the transaction at $14.48 per share. On Dec 09 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, bought 39,680 shares for $15.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 1934682880 and an Enterprise Value of 1718459264. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.14, and their Forward P/E ratio for the next fiscal year is 38.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.70 while its Price-to-Book (P/B) ratio in mrq is 4.62. Its current Enterprise Value per Revenue stands at 1.509 whereas that against EBITDA is 25.12.
Stock Price History:
The Beta on a monthly basis for PGNY is 1.42, which has changed by -0.41883516 over the last 52 weeks, in comparison to a change of 0.208081 over the same period for the S&P500. Over the past 52 weeks, PGNY has reached a high of $42.08, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is 27.00%, while the 200-Day Moving Average is calculated to be 2.73%.
Shares Statistics:
According to the various share statistics, PGNY traded on average about 1.85M shares per day over the past 3-months and 1711080 shares per day over the past 10 days. A total of 88.34M shares are outstanding, with a floating share count of 71.17M. Insiders hold about 16.43% of the company’s shares, while institutions hold 90.23% stake in the company. Shares short for PGNY as of 1736899200 were 11527008 with a Short Ratio of 6.22, compared to 1734048000 on 12202368. Therefore, it implies a Short% of Shares Outstanding of 11527008 and a Short% of Float of 17.16.
